About
Nectero Therapeutics is a clinical-stage biotech company developing novel endovascular therapies to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms using a proprietary mixture delivered via a minimally invasive system.
Explore Nectero Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.